viral-infection

Documents about viral-infection

• Oral Auranofin for Reduction of Latent Viral Reservoir in Patients With HIV Infection#912958ClinicalTrials.gov
• HIV Immune and Virological Responses Following the Administration of IL-2 Either Alone or Combined to ALVAC-HIV 1433 and HIV Lipopeptides in Patients Treated Early With HAART During Primary Infection#208286ClinicalTrials.gov
• AZithromycin Against pLacebo in Exacerbations of Asthma#845942ClinicalTrials.gov
• A Community-based Intervention Among Active Drug Users in Montpellier#902342ClinicalTrials.gov
• Cromolyn Sodium for Treatment of COVID-19 Pneumonia#993604ClinicalTrials.gov
• Interferon Reference for Older People - REFIPA Study#994759ClinicalTrials.gov
• Potential of Interface Care Models to Deliver More Appropriate Care to Patients With Acute Medical Illness#852218ClinicalTrials.gov
• Genotypic and phenotypic characteristics of CXCR4-using transmitted/founder HIV-1 envelope glycoproteins#213127HAL (France)
• The residue 86 of the Getah virus E2 glycoprotein mediates both glycosaminoglycan- and LDLR-dependent infection#418992PLOS
• Additional file 7 of LY6E regulates Pseudorabies virus early infection via impairing viral internalization#780721Figshare
• Additional file 6 of LY6E regulates Pseudorabies virus early infection via impairing viral internalization#780722Figshare
• Additional file 5 of LY6E regulates Pseudorabies virus early infection via impairing viral internalization#780724Figshare
• Additional file 4 of LY6E regulates Pseudorabies virus early infection via impairing viral internalization#780726Figshare
• Additional file 3 of LY6E regulates Pseudorabies virus early infection via impairing viral internalization#780728Figshare
• Additional file 2 of LY6E regulates Pseudorabies virus early infection via impairing viral internalization#780729Figshare
• Additional file 1 of LY6E regulates Pseudorabies virus early infection via impairing viral internalization#780730Figshare
• Raltegravir Added to Stable HAART in HIV-1 Infected Subjects With Viral Suppression and Low CD4 Recovery#825054ClinicalTrials.gov
• Zopa Retreatment and Vector Shedding in Adults With RRP#831986ClinicalTrials.gov
• Respiratory Syncytial Virus Human Challenge in Healthy Adult Volunteers#836075ClinicalTrials.gov
• Umbilical Cord(UC)-Derived Mesenchymal Stem Cells(MSCs) Treatment for the 2019-novel Coronavirus(nCOV) Pneumonia#899535ClinicalTrials.gov
• Merkel cell polyomavirus exploits extracellular vesicles for skin infection and host immune evasion through activated Wnt signaling#305592PLOS
• VRK3 promotes KSHV infection by suppressing the antiviral type I interferon response#406550PLOS
• Investigation of changes in irisin and nesfatin-1 levels in chronic viral hepatitis#446720Recep Tayyip Erdoğan University Institutional Repository
• Collecting Respiratory Sound Samples From Corona Patients to Extend the Diagnostic Capability of VOQX Electronic Stethoscope to Diagnose COVID-19 Patients#833934ClinicalTrials.gov
• Natural History of HTLV-I Infection: Prospective Follow-up of a Cohort of Blood Donors in Jamaica#891810ClinicalTrials.gov
• Efficacy Study of T Cell Vaccination in HIV Infection#994908ClinicalTrials.gov
• A Phase I/II Clinical Trial With Interferon Alfa 5 in Treatment-Experienced Patients With Genotype-1 Chronic Hepatitis C#859601ClinicalTrials.gov
• Host Response to Infection by Direct Analysis of Leukocyte Single Cell-type Gene Expression/transcript Abundance, Direct LS-TA#909059ClinicalTrials.gov
• A Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1647 Cytomegalovirus (CMV) Vaccine in Healthy Participants 16 to 40 Years of Age#911744ClinicalTrials.gov
• Efficacy of BCG Vaccination in the Prevention of COVID19 Via the Strengthening of Innate Immunity in Health Care Workers#217118ClinicalTrials.gov
• Tolerability, Safety and Immunogenicity Trial of the Flu-M Quadro, Tetravalent Inactivated Split Influenza Vaccine#444748ClinicalTrials.gov
• <i>In vivo</i> genome editing of central nervous system SIV reservoirs in ART-suppressed rhesus macaques#784477Europe PMC
• Evaluation of Maraviroc Intensification in HIV Infected Patients With Insufficient Immune Restoration#843708ClinicalTrials.gov
• Cohort of Young Adults Infected With HIV Since Birth or During Childhood#851652ClinicalTrials.gov
• Desmin mutations in cardiomyocytes increase susceptibility to coxsackievirus B3 infection by impairing antiviral IFN-β response and upregulating viral receptors expression#14387HAL (France)
• Densely sampled viral trajectories suggest longer duration of acute infection with B.1.1.7 variant relative to non-B.1.1.7 SARS-CoV-2#643633Harvard DASH
• A Phase 2a Study to Evaluate Viral Kinetics and Safety of Telaprevir in Participants With Genotype 2 or 3 Hepatitis C Infection#829216ClinicalTrials.gov
• Photodynamic Therapy for COVID-19 Prevention#853000ClinicalTrials.gov
• Parkinson's Disease in the Era of a Novel Respiratory Virus Pandemic#948141Repositorio de Universidad Autónoma de Chile.
• Early Neutralizing Antibodies in Infants Living With HIV to Enhance Their Life#1009215ClinicalTrials.gov
• Blood Collection Study From COVID-19 Convalescents Previously Hospitalized to Identify Immunogenic Viral Epitopes#875824ClinicalTrials.gov
• Theiler's murine encephalomyelitis virus as the infectious agent for a virally induced mouse model of Parkinson's disease#123209Europe PMC
• French Multicentre Observational Study on SARS-Cov-2 Infections (COVID-19) ICU Management Study#848523ClinicalTrials.gov
• Artesunate Ointment for the Treatment of Anal HSIL in HIV-negative Participants#894317ClinicalTrials.gov
• RT-PCR SARS-CoV-2 at 1 Month of COVID-19 Infection in the Geriatric Population#901490ClinicalTrials.gov
• Lamivudine and Therapeutic Vaccine Evaluation in Senegalese Patients With Chronic Hepatitis B Infection (ANRS 12100 HEPADAK-2)#1030174ClinicalTrials.gov
• Study of the Serotype and Genotype of BK Virus in Kidney Transplant Recipients and Their Donors to Identify Individuals at Risk of Nephropathy#872926ClinicalTrials.gov
• Antibodies against type I interferon: detection and association with severe clinical outcome in COVID‐19 patients#156278HAL (France)
• Subversion of the salicylic acid signaling pathway by the bipartite begomoviral protein BV1 promotes virus infection and vector preference to virus-infected plants#348433PLOS
• Cross-family and phage-specific gene requirements for <i>Klebsiella</i> infection revealed by scalable RB-TnSeq genetic screens#385447PLOS